Clinical Orthopaedics and Related Research®

, Volume 468, Issue 2, pp 441–447 | Cite as

High Survival of Uncemented Proximally Porous-coated Titanium Alloy Femoral Stems in Osteoporotic Bone

  • John B. Meding
  • Matthew R. Galley
  • Merrill A. Ritter
Symposium: Papers Presented at the Hip Society Meetings 2009


Because the initial fixation of an uncemented stem may be compromised in patients with osteoporotic bone (Class C, Dorr et al.), many surgeons prefer a cemented stem in this setting. We therefore determined the survival of an uncemented, proximally porous-coated, straight-stemmed, titanium alloy femoral component in patients with Class C bone when compared with Class A and B bone. We implanted proximally plasma-sprayed, straight-stemmed titanium alloy stems in 1994 patients (2321 hips). Of these, 625 hips (27%), 1569 hips (67%), and 127 hips (6%) were classified as Classes A, B, and C, respectively. Minimum followup was 2 years (mean, 5.9 years; range, 2–19.5 years). We identified no differences in Harris hip scores, pain, radiolucencies, or osteolysis among Classes A, B, and C hips. Stem survival at 5, 10, and 15 years for aseptic loosening (failure) was 100% in all patients with Class A bone; 99+% in all patients with Class B bone; and 100% in all patients with Class C bone. Initial stability and durable fixation can be achieved with the use of this uncemented stem in patients in whom a cemented stem traditionally has been preferred as a result of poor bone quality.

Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.


Titanium Alloy Femoral Component Aseptic Loosening Femoral Stem Radiolucency Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Dr Michael E. Berend, Dr Robert A. Malinzak, Dr E. Michael Keating, Dr Philip M. Faris, and Matthew J. Brunsman, MS, for their assistance.


  1. 1.
    Berend KR, Lombardi AV, Mallory TH, Dodds KL, Adams JB. Cementless double-tapered total hip arthroplasty in patients 75 years of age and older. J Arthroplasty. 2004;19:288–295.CrossRefPubMedGoogle Scholar
  2. 2.
    Burt CF, Garvin KL, Otterberg ET, Jardon OM. A femoral component inserted without cement in total hip arthroplasty. A study of the Tri-Lock component with an average ten-year duration of follow-up. J Bone Joint Surg Am. 1998;80:952–960.PubMedGoogle Scholar
  3. 3.
    Clohisy JC, Harris WH. The Harris-Galante uncemented femoral component in primary total hip replacement at 10 years. J Arthroplasty. 1999;14:915–917.CrossRefPubMedGoogle Scholar
  4. 4.
    Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone. 1993;14:231–242.CrossRefPubMedGoogle Scholar
  5. 5.
    Edidin AA, Merritt PO, Hack BH, Manley MT. A ported, proximally-cemented femoral stem for total hip arthroplasty. Development and clinical application. J Bone Joint Surg Br. 1998;80:869–875.CrossRefPubMedGoogle Scholar
  6. 6.
    Emerson RH, Sanders SB, Head WC, Higgins L. Effect of circumferential plasma-spray porous coating on the rate of femoral osteolysis after total hip arthroplasty. J Bone Joint Surg Am. 1999;81:1291–1298.PubMedGoogle Scholar
  7. 7.
    Gruen TA, McNeice GM, Amstutz HC. ‘Modes of failure’ of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979;141:17–27.PubMedGoogle Scholar
  8. 8.
    Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737–755.PubMedGoogle Scholar
  9. 9.
    Hozack WJ, Rothman RH, Eng K, Mesa J. Primary cementless hip arthroplasty with a titanium plasma sprayed prosthesis. Clin Orthop Relat Res. 1996;333:217–225.CrossRefPubMedGoogle Scholar
  10. 10.
    Kelly SJ, Robbins CE, Bierbaum BE, Bono JV, Ward DM. Use of a hydroxyapatite-coated stem in patients with Class C femoral bone. Clin Orthop Relat Res. 2007;465:112–116.PubMedGoogle Scholar
  11. 11.
    Meding JB, Keating EM, Ritter MA, Faris PM, Berend ME. Minimum ten-year follow-up of a straight-stemmed, plasma-sprayed, titanium-alloy, uncemented femoral component in primary total hip arthroplasty. J Bone Joint Surg Am. 2004;86:92–97.PubMedGoogle Scholar
  12. 12.
    Morrey BF. Short-stemmed uncemented femoral component for primary hip arthroplasty. Clin Orthop Relat Res. 1989;249:169–175.PubMedGoogle Scholar
  13. 13.
    Parvizi J, Keisu KS, Hozack WJ, Sharkey PF, Rothman RH. Primary total hip arthroplasty with an uncemented femoral component: a long-term study of the Taperloc stem. J Arthroplasty. 2004;19:151–156.CrossRefPubMedGoogle Scholar
  14. 14.
    Rasquinha VJ, Ranawat CS. Durability of the cemented femoral stem in patients 60 to 80 years old. Clin Orthop Relat Res. 2004;419:115–223.CrossRefPubMedGoogle Scholar
  15. 15.
    Williams HD, Browne G, Gie GA, Ling RS, Timperley AJ, Wendover NA. The Exeter universal cemented femoral component at 8 to 12 years. A study of the first 325 hips. J Bone Joint Surg Br. 2002;84:324–334.CrossRefPubMedGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2009

Authors and Affiliations

  • John B. Meding
    • 1
  • Matthew R. Galley
    • 1
  • Merrill A. Ritter
    • 1
  1. 1.The Center for Hip and Knee SurgerySt Francis Hospital, MooresvilleMooresvilleUSA

Personalised recommendations